Your session is about to expire
← Back to Search
Bridging the Gap Intervention for Violent Injury
N/A
Recruiting
Led By Nicholas Thomson
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
They receive treatment in the hospital for a violence-related injury (e.g., gunshot wound)
They are 18 years or older
Must not have
Age <18
Non-English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a hospital-based violence intervention can help reduce violence. If successful, the researchers hope to learn more about how the intervention affects other behaviors.
Who is the study for?
This trial is for English-speaking adults over 18 who live in Richmond City or nearby counties and are treated at the hospital for injuries from violence like gunshot wounds. It's not open to minors, non-English speakers, or prisoners.
What is being tested?
The study tests 'Bridging the Gap,' a hospital-based program aimed at reducing retaliatory gun violence among violently injured adults. Researchers will compare outcomes of participants with and without this intervention.
What are the potential side effects?
Since 'Bridging the Gap' is a behavioral intervention rather than a medical treatment, it does not have traditional side effects. However, participation may affect behaviors related to firearm use, drug use, aggression, risky actions, and re-injury rates.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am being treated in the hospital for an injury caused by violence.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Select...
I do not speak English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Firearm-related mortality
Firearm-related re-injury
Firearm-related violence
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: In-hospital interventionExperimental Treatment1 Intervention
Adults randomized to Bridging the Gap (BTG) services will receive a hospital-based violence prevention program with 6-months of community case management and a firearm counseling program.
Group II: Treatment as usualActive Control1 Intervention
Adults who will not receive BTG services and will receive treatment as usual (TAU) in the hospital.
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
719 Previous Clinical Trials
22,895,220 Total Patients Enrolled
Centers for Disease Control and PreventionFED
892 Previous Clinical Trials
22,000,146 Total Patients Enrolled
Nicholas ThomsonPrincipal InvestigatorVirginia Commonwealth University
3 Previous Clinical Trials
580 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am being treated in the hospital for an injury caused by violence.I am 18 years old or older.I do not speak English.You can speak English.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment as usual
- Group 2: In-hospital intervention